Merck’s Gardasil Records $70 Mil. In Sales In Q3
This article was originally published in The Pink Sheet Daily
Executive Summary
Managed care plans representing over 90% of covered lives of girls and women nine to 26 have added HPV vaccine to their respective formularies, Merck reports.
You may also be interested in...
FDA Denies Priority Review For GlaxoSmithKline’s HPV Vaccine Cervarix
Decision could give Merck’s Gardasil an extra four months without HPV vaccine competition.
FDA Denies Priority Review For GlaxoSmithKline’s HPV Vaccine Cervarix
Decision could give Merck’s Gardasil an extra four months without HPV vaccine competition.
GSK Wagers On Cervarix In Head-To-Head Trial Against Gardasil
Trial will be the first to directly compare sustained immune response in women treated with the two cervical cancer vaccines.